Occam's razor need not apply: Advanced HIV infection presenting with five simultaneous opportunistic infections and central nervous system lymphoma

被引:3
作者
Porter, Louis-Bassett [1 ]
Kozakewich, Elena [1 ]
Clouser, Ryan [2 ]
Kershaw, Colleen [3 ]
Hale, Andrew J. [2 ]
机构
[1] Univ Vermont, Med Ctr, Burlington, VT 05401 USA
[2] Univ Vermont, Larner Coll Med, Med Ctr, Burlington, VT 05401 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源
IDCASES | 2018年 / 13卷
关键词
Human Immunodeficiency Virus; Acquired Immunodeficiency Disorder; Opportunistic infection;
D O I
10.1016/j.idcr.2018.e00437
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Patients with Human Immunodeficiency Virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS) are at risk for multiple infectious and oncologic complications. In such cases, Occam's razor need not apply: multiple infections and malignancies are often present concurrently upon presentation to care. A patient off anti-retroviral therapy (ART) for several years developed advanced HIV infection (CD4 count 19 cells/uL) and presented with five simultaneous opportunistic infections including Pneumocystis jiroveci pneumonia (PJP), cytomegalovirus (CMV) retinitis, Mycobacterium avium complex (MAC) bloodstream infection, chronic hepatitis B virus (HBV), and Epstein-Barr virus (EBV) viremia. Simultaneously, he was found to have primary central nervous system (CNS) B-cell lymphoma. Treatment decisions for such patients are often complex, as ideal therapy for one disease may directly counter or interact with therapy for another. For instance, methotrexate for primary CNS lymphoma and trimethoprim/sulfamethoxazole for PJP is a strictly contraindicated medication combination. It is important to understand not just the management of any single opportunistic disease in patients with advanced HIV, but how to balance management for patients with a variety of concurrent processes. In an era when HIV care is becoming increasingly simplified, patients presenting with advanced infection highlight the lack of data on how best to manage patients with multiple concurrent disease processes. Significant further research is needed to clarify ideal comparative therapy. (C) 2018 The Authors. Published by Elsevier Ltd.
引用
收藏
页数:4
相关论文
共 16 条
[1]   Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination [J].
Al-Quteimat, O. M. ;
Al-Badaineh, M. A. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (03) :203-205
[2]  
[Anonymous], 2018, GUID PREV TREATM OPP
[3]  
Centers for Disease Control and Prevention, 2018, HIV AIDS BAS STAT
[4]   Effects of antiretroviral therapy on immunity in patients infected with HIV [J].
Feola, DJ ;
Thornton, AC ;
Garvy, BA .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (09) :1015-1022
[5]   Cryptococcal meningoencephalitis in HIV/AIDS: when to start antiretroviral therapy? [J].
Franco-Paredes, Carlos ;
Chastain, Daniel B. ;
Rodriguez-Morales, Alfonso J. ;
Marcos, Luis A. .
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2017, 16
[6]   Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease [J].
Griffith, DE ;
Brown-Elliott, BA ;
Shepherd, S ;
McLarty, J ;
Griffith, L ;
Wallace, RJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (02) :250-253
[7]   OCULAR TOXICITY OF ETHAMBUTOL AND ITS RELATION TO DOSE [J].
LEIBOLD, JE .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1966, 135 (A2) :904-&
[8]   Prophylaxis and treatment of hepatitis B in immunocompromised patients [J].
Marzano, A. ;
Angelucci, E. ;
Andreone, P. ;
Brunetto, M. ;
Bruno, R. ;
Burra, P. ;
Caraceni, P. ;
Daniele, B. ;
Di Marco, V. ;
Fabrizi, F. ;
Fagiuoli, S. ;
Grossi, P. ;
Lampertico, P. ;
Meliconi, R. ;
Mangia, A. ;
Puoti, M. ;
Raimondo, G. ;
Smedile, A. .
DIGESTIVE AND LIVER DISEASE, 2007, 39 (05) :397-408
[9]   Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium [J].
May, T ;
Brel, F ;
Beuscart, C ;
Vincent, V ;
Perronne, C ;
DocoLecompte, T ;
SaintMarc, T ;
Dautzenberg, B ;
Grosset, J ;
Blanc ;
Allegre ;
Chardon ;
Bellon ;
Gaillat ;
Charvier ;
Sedaillan ;
Guillevin ;
Jarrousse ;
Lortholary ;
DeZeeow ;
Bazin ;
Cren ;
Hazera ;
Six ;
Morel ;
Malbruny ;
Goubin ;
Dormont ;
Boue ;
Livartowsky ;
Dulioust ;
Pillot ;
Mole ;
Vinceneux ;
Borie ;
Michon ;
Boussougant ;
Portier ;
Chavanet ;
Grappin ;
Kazmierczak ;
Duez ;
DeTruchis ;
Risbourg ;
Nauciel ;
Ronco ;
Massiota ;
deRibes, C ;
Force ;
Conzi .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (03) :621-629
[10]  
Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8